BUFFALO, N.Y. – The past five years have seen significant advancements in diagnosing and treating multiple sclerosis, but challenges remain — especially among patients who are living longer, a result ...
Global experts, including several from Monash University, have developed guidelines to better manage multiple sclerosis (MS) in people over 50. Subscribe to our newsletter for the latest sci-tech news ...
Please provide your email address to receive an email when new articles are posted on . Disease-modifying therapy de-escalation may be safe in certain older patients with MS. More data are needed to ...
The National Institute for Health and Care Excellence (NICE) has recommended ublituximab (Briumvi) for treating people with relapsing remitting multiple sclerosis (MS). The drug should be available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback